Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population

LESSONS LEARNED. Modification of FOLFIRINOX significantly improves safety and tolerability in Chinese patients with locally advanced pancreatic cancer. Patients with locally advanced pancreatic cancer benefit from neoadjuvant therapy and experience a much better survival than patients with upfront s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Li, Xiang, Guo, Chengxiang, Li, Qinghai, Wei, Shumei, Zhang, Qi, Chen, Yiwen, Shen, Yinan, Ma, Tao, Li, Guogang, Gao, Shunliang, Que, Risheng, Lou, Jianying, Yu, Risheng, Yuan, Ying, Wei, Qichun, Huang, Pintong, Liang, Tingbo, Bai, Xueli
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2018
Matèries:
Clinical Trial Results
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519772/
https://ncbi.nlm.nih.gov/pubmed/30459238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0696
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars